Skip to content

Nicholas David Flint

NPI 1093465353ActiveIndividual· Dermatology· Danville, PA

Dermatology in Danville, Pennsylvania, licensed in PA, with an NPI issued in March 2022. Part D covered 261 prescriptions written in 2024, 88% of them generic. Revance Therapeutics, Inc. reported $32.34 in payments in 2025, mostly food and beverage.

Overview

NPI1093465353
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 28, 2022
Last updated in NPPESSep 11, 2026
Certified by providerSep 11, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)261 · 292 30-day fills
Patients145
Total drug cost$91,699
Generic share88% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$32.34 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Revance Therapeutics, Inc.$32.341

What the 2025 payments were for

  • Food and Beverage$32.34 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Dermatology providers in Danville

All Dermatology providers in Pennsylvania →